Actively Recruiting
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Led by West China Hospital · Updated on 2024-09-03
400
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
CONDITIONS
Official Title
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Living-donor kidney transplant recipients
- Receiving standard triad immunosuppressive regimen
You will not qualify if you...
- Active infection
- Multi-organ transplantation
- History of malignancy in the donor or recipient
- Human immunodeficiency virus infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
T
Tao Lin, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here